265 related articles for article (PubMed ID: 17305652)
21. The intake of flavonoids and carotid atherosclerosis: the Kuopio Ischaemic Heart Disease Risk Factor Study.
Mursu J; Nurmi T; Tuomainen TP; Ruusunen A; Salonen JT; Voutilainen S
Br J Nutr; 2007 Oct; 98(4):814-8. PubMed ID: 17466095
[TBL] [Abstract][Full Text] [Related]
22. Insulin resistance, metabolic syndrome, and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA).
Bertoni AG; Wong ND; Shea S; Ma S; Liu K; Preethi S; Jacobs DR; Wu C; Saad MF; Szklo M
Diabetes Care; 2007 Nov; 30(11):2951-6. PubMed ID: 17704348
[TBL] [Abstract][Full Text] [Related]
23. Rosiglitazone reduces office and diastolic ambulatory blood pressure following 1-year treatment in non-diabetic subjects with insulin resistance.
Nilsson PM; Hedblad B; Donaldson J; Berglund G
Blood Press; 2007; 16(2):95-100. PubMed ID: 17612907
[TBL] [Abstract][Full Text] [Related]
24. The effects of rosiglitazone on atherosclerotic progression in patients with Type 2 diabetes at high cardiovascular risk.
Yee MS; Pavitt DV; Dhanjil S; Godsland IF; Richmond W; Johnston DG
Diabet Med; 2010 Dec; 27(12):1392-400. PubMed ID: 21059092
[TBL] [Abstract][Full Text] [Related]
25. Correlation of common carotid artery intima media thickness, intracranial arterial stenosis and post-stroke cognitive impairment.
Lee YH; Yeh SJ
Acta Neurol Taiwan; 2007 Dec; 16(4):207-13. PubMed ID: 18220013
[TBL] [Abstract][Full Text] [Related]
26. Atherosclerosis is associated with plasminogen activator inhibitor type-1 in chronic haemodialysis patients.
Peng Y; Liu H; Liu F; Ouyang L; Cheng M; Gao L; Pan F; Liu Y; Chen X; Li J
Nephrology (Carlton); 2008 Oct; 13(7):579-86. PubMed ID: 19161364
[TBL] [Abstract][Full Text] [Related]
27. Rosiglitazone does not improve vascular function in subjects with chronic kidney disease.
Chan DT; Watts GF; Irish AB; Dogra GK
Nephrol Dial Transplant; 2011 Nov; 26(11):3543-9. PubMed ID: 21378155
[TBL] [Abstract][Full Text] [Related]
28. Kidney function and progression of carotid intima-media thickness in a community study.
Desbien AM; Chonchol M; Gnahn H; Sander D
Am J Kidney Dis; 2008 Apr; 51(4):584-93. PubMed ID: 18371534
[TBL] [Abstract][Full Text] [Related]
29. Beneficial effects of rosiglitazone on novel cardiovascular risk factors in patients with Type 2 diabetes mellitus.
Kadoglou NP; Iliadis F; Angelopoulou N; Perrea D; Liapis CD; Alevizos M
Diabet Med; 2008 Mar; 25(3):333-40. PubMed ID: 18307460
[TBL] [Abstract][Full Text] [Related]
30. Association of carotid intima-medial thickness and indices of arterial stiffness with cardiovascular disease outcomes in CKD.
Zoungas S; Cameron JD; Kerr PG; Wolfe R; Muske C; McNeil JJ; McGrath BP
Am J Kidney Dis; 2007 Oct; 50(4):622-30. PubMed ID: 17900462
[TBL] [Abstract][Full Text] [Related]
31. Thiazolidinediones: effects on the development and progression of type 2 diabetes and associated vascular complications.
Krentz A
Diabetes Metab Res Rev; 2009 Feb; 25(2):112-26. PubMed ID: 19219860
[TBL] [Abstract][Full Text] [Related]
32. Association of waist and hip circumference with 12-year progression of carotid intima-media thickness in elderly women.
Hassinen M; Lakka TA; Komulainen P; Haapala I; Nissinen A; Rauramaa R
Int J Obes (Lond); 2007 Sep; 31(9):1406-11. PubMed ID: 17372615
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of metabolite profiles as biomarkers for the pharmacological effects of thiazolidinediones in Type 2 diabetes mellitus patients and healthy volunteers.
van Doorn M; Vogels J; Tas A; van Hoogdalem EJ; Burggraaf J; Cohen A; van der Greef J
Br J Clin Pharmacol; 2007 May; 63(5):562-74. PubMed ID: 17488363
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological PPARgamma stimulation in contrast to beta cell stimulation results in an improvement in adiponectin and proinsulin intact levels and reduces intima media thickness in patients with type 2 diabetes.
Forst T; Hohberg C; Fuellert SD; Lübben G; Konrad T; Löbig M; Weber MM; Sachara C; Gottschall V; Pfützner A
Horm Metab Res; 2005 Aug; 37(8):521-7. PubMed ID: 16138267
[TBL] [Abstract][Full Text] [Related]
35. Progression of early carotid atherosclerosis is only temporarily reduced after antibiotic treatment of Chlamydia pneumoniae seropositivity.
Sander D; Winbeck K; Klingelhöfer J; Etgen T; Conrad B
Circulation; 2004 Mar; 109(8):1010-5. PubMed ID: 14769704
[TBL] [Abstract][Full Text] [Related]
36. Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE): A Randomized Controlled Trial.
Mita T; Katakami N; Shiraiwa T; Yoshii H; Onuma T; Kuribayashi N; Osonoi T; Kaneto H; Kosugi K; Umayahara Y; Yamamoto T; Matsumoto K; Yokoyama H; Tsugawa M; Gosho M; Shimomura I; Watada H;
Diabetes Care; 2016 Mar; 39(3):455-64. PubMed ID: 26822324
[TBL] [Abstract][Full Text] [Related]
37. Effect of various diuretic treatments on rosiglitazone-induced fluid retention.
Karalliedde J; Buckingham R; Starkie M; Lorand D; Stewart M; Viberti G;
J Am Soc Nephrol; 2006 Dec; 17(12):3482-90. PubMed ID: 17093067
[TBL] [Abstract][Full Text] [Related]
38. Rosiglitazone is effective and well-tolerated in a range of therapeutic regimens during daily practice in patients with type 2 diabetes.
Rosak C; Standl E; Reblin T; Stammer H; Seidel DK
Int J Clin Pract; 2006 Sep; 60(9):1040-7. PubMed ID: 16939544
[TBL] [Abstract][Full Text] [Related]
39. Elevated cholesteryl ester transfer protein concentration is associated with an increased risk for cardiovascular disease in women, but not in men, with Type 2 diabetes: the Hoorn Study.
Alssema M; Dekker JM; Kuivenhoven JA; Nijpels G; Teerlink T; Scheffer PG; Diamant M; Stehouwer CD; Bouter LM; Heine RJ
Diabet Med; 2007 Feb; 24(2):117-23. PubMed ID: 17257272
[TBL] [Abstract][Full Text] [Related]
40. Effect of ramipril and of rosiglitazone on carotid intima-media thickness in people with impaired glucose tolerance or impaired fasting glucose: STARR (STudy of Atherosclerosis with Ramipril and Rosiglitazone).
Lonn EM; Gerstein HC; Sheridan P; Smith S; Diaz R; Mohan V; Bosch J; Yusuf S; Dagenais GR;
J Am Coll Cardiol; 2009 Jun; 53(22):2028-35. PubMed ID: 19477351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
